This study is in progress, not accepting new patients
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral IR-LD/CD in Subjects With PD Experiencing Motor Fluctuations
Summary
- Eligibility
- for people ages 30-80 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- NeuroDerm Ltd.
- Links
- To contact US site near you should go to:
- ID
- NCT04006210
- Phase
- Phase 3 Parkinson's Disease Research Study
- Study Type
- Interventional
- Participants
- At least 381 people participating
- Last Updated